Fidelity Biosciences

Entry	Author	Date	Location
Mersana Adds $4M For Next-Generation “Armed” Cancer Drugs	Arlene Weintraub	05/01/12	Boston
Liazon Receives $18,200,000 New Funding Round	VentureDeal	04/24/12	New York
EnVivo Posts Positive Trial of Schizophrenia Drug	Arlene Weintraub	12/05/11	Boston
Imagen Biotech, Staffed With Eyetech Vets, Launches in NYC With Plan to Tackle Eye Diseases	Arlene Weintraub	10/25/11	New York
Biotech Funding in New York: We Have Some Catching Up to Do	Arlene Weintraub	10/21/11	New York
Fluidnet Finds $25M	Erin Kutz	08/12/11	Boston
EnVivo, Backed by Fidelity Biosciences, Tests New Weapon Against Alzheimer’s	Arlene Weintraub	07/25/11	Boston
Ultragenyx Pharmaceutical Lands $45,000,000 Series A Round	VentureDeal	06/20/11	San Francisco
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs	Luke Timmerman	05/25/11	Boston
NextWave Pharma Snaps Up $45M	Luke Timmerman	01/11/11	San Francisco
VMware Makes Two Acquisitions, Mascoma Picks Up SunOpta Unit, Vela Gets $6M, & More Boston-Area Deals News	Erin Kutz	09/08/10	Boston
Pfizer Gobbles FoldRx in Big Pharma’s Latest Rare Disease Play in Boston Area	Ryan McBride	09/01/10	Boston
ViewRay Secures $20,000,000 Series C Financing Round	VentureDeal	08/25/10	Detroit
Accuri Cytometers Raises $6M for Smaller, Cheaper Cell Analysis Instruments	Luke Timmerman	07/12/10	Detroit
Accuri Cytometers Obtains $6,000,000 Series E Round	VentureDeal	07/12/10	Detroit
Polaris Raises $234M for New Fund, BioScale Pins Down $25M, Clinical Data Nets $30M, & More Boston-Area Deals News	Erin Kutz	06/16/10	Boston
FoldRx Pharma Finds $29M, Plans to Seek Approval of First Drug in 2010	Ryan McBride	06/15/10	Boston
FoldRx Pharmaceuticals Garners $29,000,000 New Financing	VentureDeal	06/15/10	Boston
Zipcar Files for $75M IPO, Tetraphase Gets $45M, Covidien Acquires ev3 for $2.6B, & More Boston-Area Deals News	Erin Kutz	06/02/10	Boston
Tetraphase Nails $45M Round to Test Pipeline of New Antibiotics	Luke Timmerman	06/01/10	Boston
TetraPhase Pharmaceuticals Receives $45,000,000 Series C Financing	VentureDeal	06/01/10	Boston
NeuroTherapeutics Pharma Obtains $43,000,000 Series B Financing	VentureDeal	05/20/10	Detroit
Proteostasis, with San Diego Roots and Boston Home, Seeks Edge in Alzheimer’s and Parkinson’s	Luke Timmerman	05/03/10	Boston
Ironwood Pharma CEO Peter Hecht Breaks Silence on Company’s Big Biotech IPO	Ryan McBride	03/23/10	Boston
Larry Cheng on the Birth of Volition Capital	Wade Roush	01/12/10	Boston
Fidelity Ventures Team Forms Volition Capital	Wade Roush	01/11/10	Boston
Mersana Therapeutics Advancing Anti-Tumor Treatment with Novel Drug-Delivery Technology	Ryan McBride	12/08/09	Boston
Ironwood Files to Go Public, Seeks to Raise as Much as $172.5M	Luke Timmerman	11/20/09	Boston
Hey Life Sciences Fans, Remember The Deals Back in 2008…	Ryan McBride	01/05/09	Boston
Ironwood, Flush With Cash, Anticipates Big Year with Constipation Drug	Luke Timmerman	11/21/08	Boston
Page 1 of 2	next page »

Entry

Author

Date

Location

Mersana Adds $4M For Next-Generation “Armed” Cancer Drugs

Arlene Weintraub

05/01/12

Boston

Liazon Receives $18,200,000 New Funding Round

VentureDeal

04/24/12

New York